Preclinical profile of Gd-BOPTA. A liver-specific MRI contrast agent.
Vittadini
G
G
Bracco Industria Chimica SpA, Milan, Italy.
Felder
E
E
Musu
C
C
Tirone
P
P
D000085:Acetates / Q000493:pharmacokinetics / Q000494:pharmacology / Q000633:toxicity; D000818:Animals; D003287:Contrast Media / Q000493:pharmacokinetics / Q000494:pharmacology / Q000633:toxicity; D006168:Guinea Pigs; D006439:Hemodynamics / Q000187:drug effects; D008114:Liver Neoplasms, Experimental / Q000175:diagnosis*; D008279:Magnetic Resonance Imaging; D008536:Meglumine / Q000031:analogs & derivatives*; D009942:Organometallic Compounds / Q000493:pharmacokinetics / Q000494:pharmacology / Q000633:toxicity; D011485:Protein Binding / Q000187:drug effects; D051381:Rats
D000085:Acetates; D003287:Contrast Media; D009942:Organometallic Compounds; C064572:gadobenic acid; D008536:Meglumine